Aug 11, 2022 10:30am EDT Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
Aug 03, 2022 8:00am EDT Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
Jul 12, 2022 6:00am EDT Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
May 23, 2022 6:00am EDT Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting
Apr 20, 2022 6:10am EDT Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences
Apr 19, 2022 6:21am EDT Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer
Mar 03, 2022 9:19am EST Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent Filings, & AACR Meeting